Cargando…
Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients
BACKGROUND: Anticoagulation-free continuous renal replacement therapy (CRRT) was recommended by the current clinical guideline for patients with increased bleeding risk and contraindications of citrate. Nevertheless, anticoagulation-free CRRT yielded heterogeneous filter lifespan. Furthermore, the s...
Autores principales: | Zhang, Wei, Bai, Ming, Zhang, Ling, Yu, Yan, Li, Yangping, Zhao, Lijuan, Yue, Yuan, Li, Yajuan, Zhang, Min, Fu, Ping, Sun, Shiren, Chen, Xiangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501746/ https://www.ncbi.nlm.nih.gov/pubmed/34673634 http://dx.doi.org/10.1159/000519409 |
Ejemplares similares
-
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
por: Ratanarat, Ranistha, et al.
Publicado: (2023) -
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
por: O'Brien, Zachary, et al.
Publicado: (2022) -
Criteria for Continuous Kidney Replacement Therapy Cessation in ICU Patients
por: Volbeda, Meint, et al.
Publicado: (2023) -
Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
por: Zhang, Wei, et al.
Publicado: (2019) -
Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)